Wormwood in Chronic Progressive Disorders With Reduced Appetite

Pilot Trial With Wormwood to Improve Appetite in Cancer, Autoimmune Diseases, Depression and Old Age

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01126931

Enrollment

300

Registered

2010-05-20

Start date

2006-02-28

Completion date

2012-12-31

Last updated

2010-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Crohn disease, Involuntary weight loss in cancer, IgA nephropathy, Depression with reduced appetite

Brief summary

Wormwood is approved herbal medicine for the treatment of reduced appetite in Germany (Registration No.: 1339.99.99). Reduced appetite is observed in many chronic health disorders such as old age, immune disorders and cancer. Trial aims at observing beneficial effects of wormwood supplementation in various chronic disorders associated with reduced appetite

Detailed description

Supplementation with wormwood in chronic disorders associated with reduced appetite. Examples: 1. Cancer 2. Autoimmune diseases such as Crohns disease and IgA Nephropathy 3. Old age 4. Chronic stress and depression

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Appetite and weight loss * Chronic progressive disease

Exclusion criteria

* Life expectancy less than 3 months

Design outcomes

Primary

Measure	Time frame
Improvement in appetite	6-12 months

Secondary

Measure	Time frame
Improvement in quality of life	12-24 months

Countries

Germany

Contacts

Primary ContactSimone S Krebs, MD, Ph.D

simone.krebs@uniklinik-freiburg.de(+49) -761-27-3913

Outcome results